HSBC Upgrades Labcorp Holdings (LH) to Buy with Increased Price Target
HSBC has upgraded Labcorp Holdings (LH) from 'Hold' to 'Buy,' significantly raising its price target from $330 to $410 per share. The upgrade reflects optimism regarding the company's long-term growth trajectory and valuation potential. Analysts expect an expansion in Labcorp's P/E multiple, driven primarily by a robust merger and acquisition (M&A) strategy and strong operational momentum within its diagnostics business segment.
Topics: diagnostics business M&A strategy price target increase stock upgrade
Read the full article at Seeking Alpha
Part of the story Deutsche Bank Upgrades CrowdStrike to Buy with $300 Price Target (4 articles)